CryoLife
CRY
#6604
Rank
NZ$1.21 B
Marketcap
NZ$30.95
Share price
1.42%
Change (1 day)
-20.08%
Change (1 year)

Revenue for CryoLife (CRY)

Revenue in 2021 (TTM): NZ$0.43 Billion

According to CryoLife's latest financial reports the company's current revenue is NZ$0.51 Billion. In 2020 the company made a revenue of NZ$0.43 Billion a decrease over the revenue in the year 2019 that were of NZ$0.47 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for CryoLife from 2001 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)NZ$0.43 B-1.55%
2020NZ$0.43 B-8.32%
2019NZ$0.47 B5.09%
2018NZ$0.45 B38.55%
2017NZ$0.32 B5.17%
2016NZ$0.31 B23.63%
2015NZ$0.25 B0.87%
2014NZ$0.25 B2.81%
2013NZ$0.24 B7.32%
2012NZ$0.22 B9.59%
2011NZ$0.20 B2.56%
2010NZ$0.20 B4.12%
2009NZ$0.19 B6.64%
2008NZ$0.18 B10.87%
2007NZ$0.16 B16.54%
2006NZ$0.14 B17.36%
2005NZ$0.11 B11.06%
2004NZ$0.10 B4.79%
2003NZ$0.10 B-23.48%
2002NZ$0.13 B-11.26%
2001NZ$0.15 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Baxter
BAX
NZ$19.08 B 3,588.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
NZ$10.18 B 1,868.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$59.20 B 11,344.40%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Stryker Corporation
SYK
NZ$42.20 B 8,058.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Integra LifeSciences
IART
NZ$2.84 B 449.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
NZ$33.49 B 6,375.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Teleflex
TFX
NZ$5.52 B 967.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$159.50 B 30,735.98%๐Ÿ‡บ๐Ÿ‡ธ USA